TBPN cover image

Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN

TBPN

00:00

Accelergy’s biotech playbook pays off

John Coogan explains how stealth biotech startup Accelergy sold to Novartis for $2 billion and why the outcome fits a classic drug-company venture model.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app